Evidence map›Paper›PMID 40951337›Full record

SynthesisFrontiers in oncology2025

Global research trends in radiotherapy for bone metastases: a systematic bibliometric analysis.

Fadong Yin, Xuan Liu, Xianxiu Nan, Xianbin Zheng, Xinjue Shi, Jing Yuan, Liu Qiteng, Yuyan Gao

Abstract readSystematic Review
In one paragraph

Synthesis in Frontiers in oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Fadong YinBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Xuan LiuBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Xianxiu NanBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Xianbin ZhengBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Xinjue ShiBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Jing YuanBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Liu QitengBeijing Luhe Hospital, Capital Medical University, Beijing, China.
Yuyan GaoBeijing Luhe Hospital, Capital Medical University, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the development of various advanced radiotherapy techniques, research related to radiotherapy for bone metastases has made great progress, and scholars have published a large number of publications. In this study, we summarized the knowledge structure of radiotherapy for bone metastases and outlined the research hotspots through bibliometric analysis. Methods: Publications on radiotherapy for bone metastases from 1992 to 2024 were searched in the Web of Science Core Collection (WoSCC) database. Countries, institutions, authors, references, and keywords in the field were visualized using VOSviewer version 1.6.19 and CiteSpace version 6.3.R1. Results: 1303 publications from 71 countries were included in this study. The number of research publications on radiotherapy for bone metastases has been increasing year by year. The United States of America (USA) ranking first in terms of publication count and co-citation frequency. The most prolific institutions and authors were the University of Toronto and Sahgal A, while Chow E was the most co-cited author. The most co-cited paper was published by Lutz S et al. in 2011 in Internation Journal Of Radiation Oncology Physics. "stereotactic body radiotherapy", "spine metastases", "spinal cord compression", " immunotherapy" and "oligometastases" are the main keywords of the current research topics. Conclusions: The application of stereotactic body radiotherapy (SBRT) in the treatment of patients with bone metastases, especially oligometastases, has attracted extensive attention from researchers. How to choose reasonable radiotherapy for patients with complicated bone metastases has now become a research hotspot. Radiotherapy combined with immunotherapy may be the future development trend.

Indexed as

bibliometric analysisbone metastasesCiteSpaceradiotherapyVOSviewer

Identifiers

PMID40951337
PMCPMC12425760

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.